Healthcare >> Analyst Interviews >> September 14, 2001
AKHTAR SAMAD is an Equity Research Analyst and Managing Director
covering the Biotechnology sector. He was previously a senior
biotechnology Analyst at Mehta Partners (formerly Mehta and Isaly), and
Head of Healthcare Research at Oscar Gruss and Son. Mr. Samad's
scientific background is primarily in the areas of cancer and genomics.
He has authored textbook chapters and research papers on cancer and
genomics in leading scientific journals, and has organized conferences
on cancer and genomics. He was also formerly involved in a collaboration
with biopharmaceutical companies to develop a proprietary genomics
technology. Mr. Samad holds MD and PhD degrees from New York University
Medical School. His postgraduate experience was accrued at Harvard
Medical School, the National Institutes of Health and Cornell Medical
Center. Profile
effort?
Dr. Samad: We cover a mix of all subsectors of biotechnology including
the large caps such as Biogen (BGEN),
